GNRH1 and posterior cortical atrophy: Clinical trials investigating the efficacy of GnRH-directed monotherapy versus CAB with radiation therapy for unfavorable intermediate- or high-risk PCa have yielded conflicting results (42–44), leaving open the possibility that an undefined subset of patients may selectively benefit from CAB.